AAP
RVNC

Arax Advisory Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History

Arax Advisory Partners’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-476
Closed -$1.45K – 3115
2024
Q4 		$1.45K Buy
476
+267
+128% +$812 ﹤0.01% 2085
2024
Q3 		$1.09K Hold
209
– – ﹤0.01% 2226
2024
Q2 		$538 Buy
+209
New +$538 ﹤0.01% 2319